Results 61 to 70 of about 5,865,913 (286)

Association between the gut microbiota and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study

, 2023
BACKGROUND: Increasing studies have shown that there is a significant association between gut microbiota and non-alcoholic fatty liver disease. AIMS: To show the potential association between gut microbiota and non-alcoholic fatty liver disease, we ...
Li, Yu, Wang, Y, Liang, Xifeng, Han, L, Yuhan Wang, Liang, X, Chi, Cheng, Sun, J, Jing Sun, Yaning Lyu, Lyu, Y, Cheng Chi, Wang, K, Chi, C, Wang, Yuhan, Li, Y, Xifeng Liang, Linjing Han, Yu Li, Kexue Wang, Sun, Jing, Han, Linjing, Wang, Kexue, Lyu, Yaning   +23 more
core   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

The db mouse as a model for steatohepatitis [PDF]

, 2006
Includes bibliographical references.Fatty liver disease is a collective phrase for a spectrum of diseases characterised by increased liver fat content.
Sutherland, Jason Robert
core   +1 more source

Association of Nonalcoholic Fatty Liver Disease in Angiographically Proven Cases of Coronary Artery Disease

Indian Journal of Clinical Cardiology
Background The interplay between nonalcoholic fatty liver disease and coronary artery disease is increasingly recognized, drawing attention to nonalcoholic fatty liver disease, a potential contributor to atherosclerosis.
Saurabh Bhardwaj, Vinod Sharma
doaj   +1 more source

The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease

Canadian Journal of Gastroenterology and Hepatology, 2016
Nonalcoholic fatty liver disease is becoming one of the most common causes of liver disease in the western world. The most significant risk factors are obesity and the metabolic syndrome for which bariatric surgery has been shown to be an effective ...
Jordan J. Nostedt, Noah J. Switzer, Richdeep S. Gill, Jerry Dang, Daniel W. Birch, Christopher de Gara, Robert J. Bailey, Shahzeer Karmali   +7 more
doaj   +1 more source

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić, Christina Antza, Anastasios Poutachidis, Smaro Palaska, Elvira Meni Maria Gkrinia, Andrea Katrin Faour, Yusuf Ziya Sener, Seher Sener, Rehena Sultana   +8 more
wiley   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease

Patologìâ, 2015
Aim. Cardiovascular diseases are observed more frequently in patients with gout as compared to other rheumatologic pathologies. Methods and results.
S. I. Smiyan, S. V. Danchak
doaj   +1 more source

New therapeutic options for metabolic‐associated steatotic liver disease

British Journal of Clinical Pharmacology, EarlyView.
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley   +1 more source

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis

BMC Gastroenterology, 2018
Background Several studies have emerged indicating that sarcopenia is associated with nonalcoholic fatty liver disease, we aimed to systematically review and quantify the association between sacropenia and the histological severity of nonalcoholic fatty ...
Rui Yu, Qiangwei Shi, Lei Liu, Lidong Chen   +3 more
doaj   +1 more source